Company Overview and News
We think the company still has considerable tailwinds behind it, like a growing WFE market and increasing process control intensity.
U.S. tech companies can finally breathe easy, at least for the time being. U.S. Treasury Secretary Steve Mnuchin on Sunday said that the U.S.-China trade conflict has been put on hold.
U.S. tech companies can finally breathe easy, at least for the time being. U.S. Treasury Secretary Steve Mnuchin on Sunday said that the U.S.-China trade conflict has been put on hold. This certainly is good news for U.S. tech companies, particularly chipmakers, which have been reeling under pressure since the two countries sparked fears of a trade war by imposing tariffs and counter tariffs on imports from the two countries.
Applied Materials Inc. (NASDAQ: AMAT) typically has beaten its earnings and sales expectations. Apparently, the top U.S. player for semiconductor capital equipment is finding out that 29% in quarterly revenue growth (to $4.57 billion) and a 54% jump in operating income (to $1.22 per share) from a year ago aren’t enough in the face of expectations ahead.
If you are looking to invest in potential stocks from the semiconductor space, you can’t ignore NVIDIA Corporation (NASDAQ:NVDA).
If you are looking to invest in potential stocks from the semiconductor space, you can’t ignore NVIDIA (NVDA - Free Report) . For the past two years, NVIDIA has been impressing investors with its stellar performance, wherein the company’s quarterly revenues have been advancing at a rate more than 50%, earnings have tripled and shares have displayed more than six-fold growth, consequently. Moreover, in the year so far, the stock has rallied 26.
Growth stocks can be some of the most exciting picks in the market, as these high-flyers can captivate investors’ attention, and produce big gains as well. However, they can also lead on the downside when the growth story is over, so it is important to find companies which are still seeing strong growth prospects in their businesses. One such company that might be well-positioned for future earnings growth is KLA-Tencor Corporation (KLAC - Free Report) .
One stock that might be an intriguing choice for investors right now is KLA-Tencor Corporation (KLAC - Free Report) . This is because this security in the Semiconductor Equipment - Wafer Fabrication space is seeing solid earnings estimate revision activity and is in great company from a Zacks Industry Rank perspective.
KLA-Tencor recently reported its quarterly earnings and QoQ revenue growth was the lowest among a group of four competitors.
46 of 52 Nasdaq Index dividends were presumed "safer" because they showed positive one-year returns and free cash flow yields greater than dividend yields as of 5/4/17.
Chicago, IL – May 7, 2018 – Zacks Equity Research highlights Urban Outfitters(URBN - Free Report) as the Bull of the Day and Credit Suisse (CS - Free Report) as the Bear of the Day. In addition, Zacks Equity Research provides analysis onHarsco Corp. (HSC - Free Report) , KLA-Tencor (KLAC - Free Report) , Grupo Simec SA de DV (SIM - Free Report) .
"The Nasdaq-100 Index includes 100 of the largest domestic and international non-financial companies listed on The Nasdaq Stock Market based on market capitalization." 52 pay dividends.
It was a great week for semiconductor stocks. After the initial scare related to Taiwan Semiconductor’s (TSM - Free Report) warning about smartphone demand, investors entered the earnings season with trepidations. But after the first few earnings this week, sentiments started shifting, culminating in the reaction to Advanced Micro Devices’ (AMD - Free Report) stellar quarter.
KLA-Tencor Corporation (KLAC - Free Report) reported third-quarter fiscal 2018 earnings of $2.02 per share, beating the Zacks Consensus Estimate by 4 cents. The figure surged 25% from the year-ago quarter and rose 3% sequentially.
Good day. My name is Jeff and I'll be your conference operator today. At this time, I'd like to welcome everyone to the KLA-Tencor Third Quarter Fiscal Year 2018 Earnings Conference Call. All lines have been placed on mute to prevent any background noise. After the speakers' remarks, there will be a question-and-answer session. Thank you.
2018-05-21 - Asif
Overview Anthera Pharmaceuticals, Inc. is a biopharmaceutical company focused on advancing the development and commercialization of innovative medicines that benefit patients with unmet medical needs. The company currently have two compounds in development, Sollpura and blisibimod. The company licensed Sollpura from Eli Lilly & Co (“Eli Lilly”) in July 2014. Sollpura is a novel non-porcine investigational Pancreatic Enzyme Replacement Therapy (“PERT”) intended for the treatment of patients with Exocrine Pancreatic Insufficiency (“EPI”), often seen in patients with cystic fibrosis and other conditions. The company licensed blisibimod from Amgen, Inc. (“Amgen”) in December 2007. Blisibimod targets B-cell activating factor, or BAFF, which has been shown to be elevated in a variety of B-cell mediated autoimmune diseases, including Immunoglobulin A nephropathy, or IgA nephropathy. Sollpura The exocrine pancreas is responsible for synthesis and secretion of digestive en...
2018-05-21 - Asif
Business Agenus is a clinical-stage immuno-oncology (“I-O”) company dedicated to becoming a leader in the discovery and development of innovative combination therapies and committed to bringing effective medicines to patients with cancer. The company's business is designed to drive success in I-O through speed, innovation, and effective combination therapies. Agenus has assembled fully integrated capabilities from novel target discovery, antibody generation, cell line development, and good manufacturing practice (“GMP”) manufacturing together with a comprehensive portfolio consisting of antibody-based therapeutics, adjuvants and cancer vaccine platforms. The company leverage its immune biology platforms to identify effective combination therapies for development and have developed productive partnerships to advance its innovation. The company believe the next generation of cancer treatment will build on clinically validated antibodies targeting CTLA-4 and PD-1 combined wi...
2018-05-21 - Asif
Business The company started Square in February 2009 to enable businesses (sellers) to accept card payments, an important capability that was previously inaccessible to many businesses. However, sellers also need innovative solutions to thrive, and Square has since expanded to provide additional products and services to give these businesses access to the same tools as large businesses. This approach aligns with its purpose of economic empowerment, as everything the company do should give sellers accessible, affordable tools to grow their businesses and participate in the economy. Square is a cohesive commerce ecosystem that helps its sellers start, run, and grow their businesses. The company combine sophisticated software with affordable hardware to enable sellers to turn mobile and computing devices into powerful payment and point-of-sale solutions. Square has high seller acceptance rates and fast onboarding, while maintaining low risk and fraud losses as a result of its a...
as of ET